What is the UCB Patient Assistance Program?
Through the UCB Patient Assistance Program, we provide some medications at no cost to eligible and qualified patients who are uninsured or underinsured who otherwise have no access to the UCB medicines prescribed by their physician.
What is Neupro used to treat?
In the US, Neupro® (Rotigotine Transdermal System) is indicated for the treatment of Parkinson's disease.
Why choose UCB for your dog?
Their partnership ensures that each dog gets the extensive training that it needs, and that more needs of the epilepsy community are met. UCB, Inc. is committed to building the lives of US epilepsy patients and their family members/caregivers.
What is UCB's mission statement?
Staying true to our core beliefs, UCB is committed to ensuring patients, whose physicians have prescribed our medications, have uninterrupted access to their needed treatments.
IMPORTANT NOTE
if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition you can contact us using the webform available here
Epilepsy Advocate
Epilepsy Advocates are people living with epilepsy and caregivers seeking the best treatment for controlling their seizures with minimal side effects.
Canine Assistants programme
Canine Assistants was founded in Alpharetta, Georgia, in 1991. This nonprofit organization is dedicated to providing service dogs to children and adults with epilepsy, physical disabilities, and other special needs.
Support of patient organisations in Europe
UCB is committed to comply with Industry self-regulated codes, including the EFPIA Code of Practice on Relationships Between the Pharmaceutical Industry and Patient Organisations.
How to enroll in UCB Pharma?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call UCB Pharma program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
What is UCB Pharma?
UCB Pharma is currently a world leader in antibody research, with over thirty major research and development partners. Their operations span over forty countries, and netted over $3 billion in 2007 alone.
How long does Neupro last?
Neupro Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Neupro at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
When was Neupro first used?
Neupro is a patch treatment launched by UCB Pharma in 2007. Neupro has been approved by the FDA to treat the onset of Parkinson’s disease. Neupro is administered transdermally via a patch.
